BRO vs TERN · P/E 30, rev $4.80B vs $6.12B cap
Brown & Brown Inc (BRO) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. TERN currently screens at market cap $6.12B.
Not investment advice. Open the BRO and TERN stock pages for the full models.
Not investment advice.